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Sllnunary 
Recent observations suggest that the src-related tyrosine protein kinase p59~ may be involved 
in antigen-induced T lymphocyte activation.  As a result of alternative splicing, p59~ exists as 
two isoforms that differ exclusively  within a short sequence spanning the end of the Src Homology 
2 (SH2) region and the beginning of the tyrosine protein kinase domain. While one p59~ 
isoform (fynB) is highly expressed in brain, the alternative product (fynT) is principally found 
in T lymphocytes.  To further understand the role of p59~ in T cell activation  and to test the 
hypothesis that p59~  T serves a tissue-specific function in T lymphocytes, we have examined the 
effects of expression of activated versions (tyrosine 528 to phenylalanine 528 mutants) of either 
form of p59~ on the physiology of an antigen-spedfic mouse T cell hybridoma. Our results 
demonstrated that the two forms offyn, expressed in equivalent amounts, efficiently enhanced 
antibody-induced T cell receptor (TCR)-mediated signals. In contrast,  only p59~  T increased 
interleukin 2 production in response to antigen stimulation.  This finding implies that the distinct 
p59~  isoform expressed in T  lymphocytes regulates  the coupling of TCtL  stimulation by 
antigen/major histocompatibility complex to lymphokine production. 
ntigen-induced T lymphocyte activation is primarily medi- 
ated by changes in intracellular  tyrosine protein phos- 
phorylation (for review, see reference 1). Although the cel- 
lular machinery regulating this biochemical  signal remains 
poorly characterized, recent observations suggest that the sre- 
related nonreceptor tyrosine protein kinases p56  ~  and p59~ 
are involved in this process, p56  lck is a lymphocyte-specific 
tyrosine protein kinase associated with and regulated by the 
CD4 and CD8 T cell surface antigens (for review, see refer- 
ence 2). Increasing evidence demonstrates  that a large part 
of the accessory function provided by CD4 or CD8 during 
T  cell activation  is mediated through p561r  Contrary to 
p56 lCk, p59~ is expressed in most cell types (3-6). It is in- 
teresting that as a result of alternative splicing of mutually 
exclusive exons  7,  p59~  exists as two isoforms  differing 
solely within a stretch of 51 amino acids spanning the end 
of the SH21 region and the beginning of an otherwise clas- 
sical tyrosine protein kinase domain (see Fig.  1 A) (7).  It 
has been postulated that as a consequence of different sub- 
strate specificities and/or catalytic efl~ciencies,  these two en- 
zymes regulate distinct cellular processes. 
Whereas onefyn isoform 0CynB)  accumulates highly in brain, 
the other (fynT) is expressed predominantly in T  lympho- 
cytes (7; L. M. L. Chow, A. Veillette, D. Davidson, unpub- 
lished data). The limited homology (53% or less) between 
the exon 7-encoded sequences offynT and those off, B, as 
well as of all other src-related tyrosine protein kinases, fostered 
the early view that p59~  T plays a specialized role in T lym- 
phocyte physiology. The subsequent  demonstration that a 
fraction of p59~  T is physically associated with elements of 
the TCR complex suggested that this polypeptide may in 
fact regulate antigen receptor-induced signals (8). Additional 
support for this possibility was recently provided by the ob- 
servation that thymocytes of transgenic mice overexpressing 
either p59~ isoform showed enhanced TCR-induced tyro- 
sine protein  phosphorylation,  calcium response,  and 11.-2 
production (9). However, no significant difference between 
the functions of p59  fy~ and p59  fy~ were noted in this study. 
1 Abbreviations used in this paper: RAM,  rabbit  anti-mouse;  SH2,  Src 
Homology Domain 2; UT, untranslated. 
Materials and Methods 
Cells.  The antigen-specific  murine T cell hybridoma BI-141 (10) 
and BI-141-derived cell lines were grown in RPMI 1640 medium 
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NY), penicillin, and streptomycin. Note that specific  ribonuclease 
protection assays  showed that parental BI-141 cells e~clusively  ex- 
pressfynT  transcripts (L. M. L. Chow, A. Veillette, and D. Davidson, 
unpublished observations). The IL-2--dependent  HT-2 indicator cells 
(11) were cultured in RPMI 1640 medium supplemented as men- 
tioned above, and also containing 50 U/ml rlL-2 and 55/~M B-ME 
(Gibco Laboratories). FT 5.7 cells are L fibroblasts expressing the 
hybrid class II MHC molecule A~A~ (kindly provided by Ron 
Germain, National Institutes of  Health, Bethesda,  MD). They were 
grown in HAT-supplemented alpha MEM containing 10% FCS 
and antibiotics. All cells were maintained at 37~  in a humidified 
COz incubator. 
Site-directed  Mutagenesis.  Wild-type murinefynT (MM23) and 
fynB (MB1) complementary DNAs (cDNAs) were provided by 
M. P. Cooke and R. M. Perlmutter (University of Washington, 
Seattle, WA) (7). All mutations were introduced  by oligonucleotide- 
directed mutagenesis of uracil-enriched double-stranded plasmid 
DNA, as described by Slilaty et al. (12). Initially, an EcoRI site 
was introduced at position 210 of the 5' untranslated (UT) region 
of the fynT cDNA MM23 (using the oligonucleotide 5'AAGC- 
TCCCGAATTCCCACCAACTY).  This allowed subsequent re- 
moval of most of the 5' UT sequences of MM23 through standard 
rDNA technology. As this portion of the cDNA contains mul- 
tiple AUG codons, it may repress the translation offyn mRNAs 
(13). Then, to generate activated versions of p59~, tyrosine 528 
was  mutated  to  a  phenylalanine using  the  oligonucleotide 
5'CGGGCTGAAACTG~Y. The mutant fynB cDNA was 
created by e~hanging the ApaI-BamHI fragment of  MM23 (which 
contains the seventh exon) with that of thefynB cDNA MB1. All 
exchanged fragments were fully resequenced and found to contain 
no additional mutations (data not shown). Similarly  kinase-negative 
variants of F528 p59~T and F528 p59~ were engineered by in- 
troducing a lysine to methionine substitution at position 296 of 
the ATP-binding site of these polypeptides using oligonucleotide- 
directed mutagenesis (mutagenic oligonucleotide: 5'TAAGGGT- 
CATTATGGCTY). An identical mutation in other tyrosine pro- 
tein kinases has been shown to abolish catalytic activity (14). After 
fully resequencing to ensure that no additional mutations were in- 
troduced, the smallest restriction fragments containing the mu- 
tated nucleotide were substituted for the equivalent fragments in 
the activated fyn cDNAs. 
Retroviral Expression Vectors.  The  wild-type  or  mutant fyn 
cDNAs were inserted in the EcoKI site of the retroviral expression 
vector pLXSN (provided by D. Miller, Fred Hutchinson Cancer 
Center, Seattle, WA) (15). Generation of retrovirus packaging cell 
lines and retrovirus stocks, as well as retroviral infection of BI-141 
cells, were performed  as described  previously  (16). Cells  were selected 
for growth in media containing 750 #g/ml G418 and monoclonal 
cell lines established by limiting dilution. Cells expressing the ne- 
omycin resistance gene (neo) alone, or the activated versions of 
p56  ~ (F505 p56  m) have  been described elsewhere (16). BI-141 cells 
expressing mouse CD4 (CD4 FL3) were also generated  by retroviral 
infection  with a construct in which a full-length  mouse CD4 cDNA 
(kindly provided by Jane Fames, Stanford University, Palo Alto, 
CA) was inserted into the EcoRI site of pLXSN (L. Caron and 
A. Veillette, unpublished data). 
RNA Isolation and Northern Blot Analysis.  Total  cellular KNA 
was prepared from frozen cell  pellets  by the guanidine  isothiocyanate 
method (17). For Northern blot analysis,  10/.Lg  of  RNA was resolved 
on 1.1% agarose, 2.2 M formaldehyde  gels, and transferred  to nylon 
membrane  by vacuum  blotting. After baking the membrane  at 80~ 
for 2 h and cross-linking the nucleic acids with UV light for 5 
min, the membrane  was prehybridized  in a solution containing 50% 
formamide, 5x  SSC (lx  SSC is: 150 mM NaCI, 15 mM sodium 
citrate), 0.5% SDS, 50 mM sodium pyrophosphate, 1￿  Denhardt 
solution, and 100/xg/ml salmon sperm DNA for 15 h at 42~ 
Hybridization was carried out at 42~  for 18 h in a similar solu- 
tion with the addition of 10% dextran sulfate  and 2 x  104 cpm/ml 
of randomly primed 32P-labeled probe (18). Two brief washes in 
2x  SSC and 0.1% SDS at 25~  and one 30-min wash in 0.1x 
SSC, and 0.1% SDS at 55~  were done before autoradiograpby. 
Fyn-s~cific  IraraunoblotAssay.  Equivalent  numbers of  ceils  were 
lysed in sample buffer and tysates  resolved on 8% SDS-PAGE gels. 
Subsequent immunoblotting was conducted as described previously 
(19), using a rabbit anti-fyn  serum generated  by immunization with 
a trpE fusion protein containing residues 25-141 of the murine 
p59~ sequence (7). This peptide corresponds to sequences located 
within the unique and Src Homology 3 (SH3) domains of p59~, 
which are therefore common to fynT and fynB. This antiserum 
specifically  recognized p59~ in both immunoprecipitation and im- 
munoblot  assays. It did not react with p56  ~k (our unpublished 
data). For quantitation,  bands were cut from nitrocellulose and 
counted in a gamma counter. The presence of equivalent amounts 
of proteins in each lane was subsequently confirmed by staining 
of nitrocellulose filters with amido black. 
Antibody-mediated Cross-linking and Antiphospkotyrosine  Iramuno. 
blots.  These assays  were done as described  elsewhere (20, 21). The 
anti-TCR and -CD3 mAbs have been reported previously (22-24). 
Titration of the amount of mAb F23.1 used for cross-linking re- 
vealed that the antibody-ioduced tyrosine protein phosphorylation 
dose-responses were similar for F528 p59~T and F528 p59~ ex- 
pressing cells (unpublished  observations). Antibody-mediated  cross- 
linking was also performed using biotinylated primary antibodies 
and avidin. Incubation with avidin  was for 5 rain. Biotinylated  anti- 
TCIk mAb F23.1 and anti-CD45 mAb 30-Fll were kindly provided 
by Jeff Ledbetter (Bristol-Myers-Squibb, Seattle, WA). Antiphos- 
photyrosine immunoblotting was performed using afflnity-purified 
polyclonal  rabbit anti-phosphotyrosine antibodies (our unpublished 
data). Quantitation  was performed as outlined above. 
11,2 Assays.  To evaluate antibody-induced Ib2 production by 
the different BI-141 cell lines, wells of  96-well Falcon tissue culture 
plates were coated in triplicate with serial dilutions of mAb F23.1 
at 37~  overnight. After removal of the unbound antibody, 2  x 
104 BI-141 derivatives  were added in 200/~1 tissue culture medium 
and incubated at 37~  for 24 h. 50/~1  of superuatant were removed, 
frozen for I h at - 70~  to destroy carry-over  cells, and then tested 
for IL-2 content. This was performed by measuring [3H]thymidine 
incorporation  in  104  Ib2-dependent HT-2 indicator cells (11). 
HT-2 ceils did not respond to mAb F23.1 alone (our unpublished 
data). Controls were without addition. 
To  test  antigen-induced  IL-2 production,  BI-141 cells (10  s 
cells/well) were plated in triplicate with 5  x  104 irradiated MHC 
class II A~A~  -transfected  L cells (FT 5.7) in 96-well flat-bottomed 
tissue culture plates containing serial dilutions of beef insulin in 
a final volume of 200/~1 tissue culture medium (25). After incuba- 
tion at 370C for 24 h, supernatants were collected and assayed  for 
II:2 content as described above. Controls were without any addition. 
Results 
To better understand the role of p59%  T in mature T cell 
physiology, we have introduced constitutively activated ver- 
sions  of murine p59~  T and p59%  B in the CD4-negative, 
class II MHC-restricted beef insulin-specific  murine helper 
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tides were generated by mutating a COOH-terminal site of 
tyrosine phosphorylation (tyrosine 528) to a phenylalanine 
residue, which cannot be phosphorylated (F528 p59~ mu- 
tants; Fig. 1 A). Phosphorylation of this conserved tyrosine 
residue represses the enzymatic function of src-related tyro- 
sine protein kinases (26; for review, see reference 27). Cells 
were selected for resistance to the aminoglycoside G418 and 
individual clones isolated by limiting dilution. Clones were 
first assayed for expression of the appropriate retroviral tran- 
script by Northern blot analysis (Fig.  1 B). Four cell lines 
expressing comparable levels of either of the two mutantfyn 
tLNAs (Fig. 1 B, lanes 3-6 and 7-10) were randomly selected 
for further studies. BI-141 cell lines expressing the neomycin 
marker alone (Neo; Fig. 1 B, lane 2) or comparable amounts 
of transcripts  encoding an activated version of p56 Ic~ (F505 
p56~; Fig. 1 B, lanes II-I3) (16) were also included in these 
analyses. A subsequentfyn-specific immunoblot assay revealed 
that F528 p59~ expressing cells (Fig. 1 C, lanes 4-11) con- 
tained 1.5-3  times more p59~  than parental  BI-141 cells 
(Fig. 1 C, lane 1) or control Neo dones (Fig. 1 C, lanes 2 
and 3). This level of overexpression most likely reflects the 
high levels of endogenous p59 fynv in BI-141 cells. All cell 
lines expressed levels of TCR,  CD3,  Thyl.2, CD45,  and 
p56  lck that were identical  to those of parent BI-141 cells. 
Moreover, all clones remained CD4-negative (data not shown). 
Tyrosine protein phosphorylation is the earliest biochem- 
ical alteration detected after antigen receptor stimulation (1). 
It is important to note that, as shown by studies using tyrosine- 
specific protein kinase inhibitors,  this signal is a prerequisite 
for the subsequent increase in intraceUular calcium and IL-2 
production (28, 29). To investigate the ability of the twofyn 
isoforms to contribute to antigen receptor signaling, the effects 
of expression of these polypeptides  on TCR-induced tyro- 
sine protein phosphorylation were examined using an an- 
tiphosphotyrosine immunoblot assay (Fig. 2). Upon stimu- 
lation with anti-TCR mAb F23.1 and rabbit  anti-mouse 
(RAM) IgG, we found that cells expressing F528 p59~  v 
(Fig.  2 A,  lanes  7-12) or  F528  p59~  (Fig.  2 A,  lanes 
13-18) demonstrated more rapid, robust, and sustained tyro- 
sine protein phosphorylation signals than control cells (Fig. 
2 A, lanes I-6). Similar results were noted after stimulation 
with anti-TCR mAb H57.597 or anti-CD3 epsilon mAb 145- 
2Cll (data not shown). Although the pattern and duration 
of substrate tyrosine phosphorylation were generally the same 
for cells expressing eitherfyn mutant, quantitative analyses 
suggested that tyrosine phosphorylation of certain substrates 
(p70 and p36) was more prolonged in p59~  T than p595'~ 
expressing cells. Both mutants also augmented baseline tyro- 
sine phosphorylation of polypeptides  migrating at 100, 85, 
59, and 54 kD. The substrates showing augmented TCR- 
induced tyrosine phosphorylation in F528 p59~ expressing 
cells (Fig. 2 B, lanes 5-I2) had the same apparent molecular 
weights as those previously shown to be regulated by F505 
p56  lck (Fig. 2 B, lanes 13-16) (16). However,  the enhance- 
ment by F528 p59~ was generally less than that conferred 
by the activated kk polypeptide. 
Previous studies have shown that the CD45 tyrosine phos- 
phatase can significantly modulate antigen receptor-induced 
signals (1, 2). This implies that such an enzyme may physio- 
logically regulate the tyrosine protein kinases mediating the 
TCR-induced signals. Thus, in an attempt to further charac- 
terize the mechanisms by which the twofyn isoforms regn- 
late TCR-induced tyrosine protein phosphorylation, the effects 
of coaggregation of TCR with CD45 were evaluated (Fig. 
2 C). As is the case for Neo expressing cells (Fig. 2 C, lane 
4),  or  cells containing F505 p56  lck (Fig.  2  C,  lane  16), 
coaggregation of TCR with CD45 on F528fynT (Fig. 2 C, 
lane 8) or F528 fynB (Fig.  2 C,  lane 12) expressing cells 
abrogated anti-TCR antibody-induced tyrosine protein phos- 
phoryhtion (Fig. 2 C, lanes 3, 7, II, and I5). Coupled with 
the findings reported above, this result suggests that the acti- 
vated p59~ variants, as well as activated p56  lck, regulate an- 
tigen receptor-mediated signals through overlapping and pos- 
sibly similar mechanisms. 
We next wanted to ascertain whether the enhancement 
of TCR-induced signals by fyn resulted  in improved lym- 
phokine production (Fig. 3). To this end, calls were stimu- 
lated with anti-TCR mAb F23.1 immobilized on plastic and 
IL-2 production was assayed using the IL-2-sensitive cell line 
HT-2  (Fig.  3 A).  When compared with Neo cells, F528 
p59~  x and F528  p59  ~a3 expressing  cells demonstrated a 
comparable and marked enhancement of antibody-induced 
Ib2 production. This was most obvious at low concentra- 
tions of antibody (30 and 100 ng/ml), at which no response 
was noted in control cells. In fact, IL-2 release after stimula- 
tion with 30 ng/ml of mAb F23.1 tended to be more sub- 
stantial  for cells expressing F528 p59~  s. 
Cell lines were also tested for reactivity to beef insulin 
presented in association with the appropriate class II MHC 
molecnles (A~A~). Two assays, representative of a total  of 
eight independent experiments,  are shown in Fig. 3, B and 
C. These studies revealed that cells expressing F528 p59~  T 
had significantly improved antigen/MHC-induced IL-2 re- 
sponses when compared with control Neo cells. Surprisingly, 
this was not the case for cells expressing equivalent amounts 
of F528 p596~,  which had essentially unaltered responses 
to antigen (Fig. 3, B and C). Only one F528 p59~ clone 
(FynB F18, Fig. 3 C) showed a small but consistent increase 
in antigen-induced lymphokine production. The improve- 
ment of antigen responsiveness  by F528 p59~  T was less than 
that conferred by expression of CD4 or F505 p56 zck in BI- 
141 cells. A comparison with representative clones is included 
in the experiment depicted in Fig. 3 C. 
We finally verified that the enhancement of T cell respon- 
siveness by F528 p59~ was related to the elevated tyrosine 
protein kinase activity of this mutant. To this effect, F528 
fynT and F528fFd/polypeptides with abolished catalytic ac- 
tivity (M296F528 p59~) (Fig. 4) or wild-typefyn proteins 
(Fig. 5) were expressed in BI-141 cells. Cell lines containing 
equivalent amounts ofretroviralfyn transcripts were sdected 
for comparison with F528 p59~ expressing cells (Fig. 4 A, 
and data not shown). The M296F528 p59~ expressing ceils 
contained 1.5-2.5-fold higher levels offyn protein than con- 
1485  Davidson et al. Figure 1.  Expression of F528 p59~ in BI-141 ceils. (A) Retroviral constructs. The activatedfynT andfynB mutants were inserted into the retroviral 
vector pLXSN at a convenient  multiple cloning site flanked by the 5' Moloney Murine Sarcoma Virus (MoMSV) LTIL and the 3' Moloney Murine 
Leukemia Virus (MoMLV) LTIL. The neomycin  (neo) phosphotransferase  gene (Tn5) is driven by the SV40 early promoter. The position of ~b + se- 
quences is shown. (Arrows) Start sites and direction of transcription. (/d) Position of the polyadenylation signal. K296 is the lysine residue at position 
296 of p59~ and is part of the ATP-binding site. Y528, which represents  the major site of in vivo tyrusine phosphorylation of p59fy  ., tyrosine 528, 
was replaced through site-directed mutagenesis  by phenylalanine  (F528),  as described in Materials and Methods. Exon 7 is designated 7A infynB and 
7B inf~T.  (8) Northern blot analysis. Expression of retroviral construct-encoded transcripts was assayed  in donal BI-141 cell lines infected with retroviruses 
encoding the neomycin phosphotransferase  alone (lane 2), F528 p59f~  T (lanes 3-6), F528 p59ry  '~ (lanes 7-I0), and, for comparison, F505 p561ck (lanes 
11-13). ILNA from parental BI-141 cells was also assayed as negative  control (lane I). Lanes 1:BI-141 parent; 2: Neo 2; 3: FynT F2; 4:  FynT F7; 
5: FynT F12; 6: PyrtT F19; 7: FynB F13; 8: FynB F15; 9: FynB F17; 10: FynB F18; 11: Lck F7; 12: Lck F9, and 13: Lck F13. The probe used for 
hybridization was a 687-bp  HindlII-NaeI fragment from pLXSN that encompasses  the majority of the neomycin  resistance  gene (neo) (Fig.  1 A). 
This probe recognized the chimeric retroviral transcript initiating from the 5' MoMLV LTIL, incorporating the sequences inserted in the multiple 
cloning site and terminating at the polyadenylation signal downstream of the neo gene. This was done to allow adequate comparison of the abundance 
of retroviral construct-encodedfyn and kk transcripts in BI-141 derivatives. (1~) designates hybridfyn and/ck messages (6.0 kb) produced by the retruviral 
vectors. The other RNA species detected at 3.1 and 1.9 kb are retroviral vector-encoded  transcripts.  (Right)  Positions  of the 28S and 18S ribosomal 
RNAs. Exposure: 6 h. (C)fyn immunoblot. Levels of p59~ were measured in parental BI-141 cells (lane I) and in cell lines expressing the neomycin 
phosphotransferase  alone (lanes 2 and 3), F528 p59~  T (lanes 4-7) and F528 p59fi  '~B (lanes 8-11), using afire-specific immunoblot assay. Lanes I: BI-141 
parent; 2: Neo 2; 3: Neo 4; 4: FynT F2; 5: FynT F7; 6: FynT F12; 7: FynT F19; 8: FynB F13; 9: FynB F15; 10: FynB F17, and 11: FynB F18. The 
immunoreactive spedes detected at 56 and 54 kD appear to be proteolytic cleavage products of p59~ (our unpublished observations).  (Left) Position 
of p59~y  n and (right) positions of prestained molecular weight markers (in kD). Exposure: 4 h. Levels of p59fy  n expression were quantified as described 
in Materials and Methods and, relative to the average of Neo cells, are as follows: FynT F2: 1.8; FynT F7: 2.1; FynT F12: 1.6; FynT F19: 1.5; FynB 
F13: 2.4;  FynB F15:  1.9; FynB F17: 2.3, and FynB F18: 2.7. 
1486  Regulation of T  Cell Function by p59fy  n Figure 2.  Enhancement  of TCK-induced tyrosine protein phosphoryhtion signal by F528 p59~. Antiphosphotyrosine  immunoblots. (A) T'tme  course 
experiments. Antibody-mediated  cross-linking of clonal BI-141  cell lines expressing the neomycin  phosphotransferase (Neo 1; lanes I-6), F528 p59~  T 
(FynT F2; lanes 7-12)  and F528 p59fY  ~  (FynB F13; lanes 13.-18) was performed with  anti-TCR mAb F23.1 and RAM IgG for variable periods of 
time at 37~  as described in Materials and Methods. Lanes I, 7, and 13: untreated controls; lanes 2, 8, and 14: mAb F23.1 +  RAM IgG for 1 min; 
lanes 3, 9, and 15: mAb F23.1  +  RAM IgG for 5 min; 4,  10, and 16: mAb F23.1  +  RAM IgG for 10 min; lanes 5,  11, and 17: mAb F23.1  + 
RAM IgG for 15 min; lanes 6, I2, and 18: mAb F23.1 +  RAM IgG for 30 min. Exposure: 12 h. Compared to Neo expressing cells, the enhancement 
of tyrosine phosphorylation after 1 rain of cross-linking is: FynT: p120: 2.7-fold; pl00: 3.4-fold; p74: 3.5-fold; p70: 3.0-fold, and p36: 4.4-fold. FynB: 
p120: 2.9-fold; pl00: 2.4-fold; p74: 3.8-fold; p70: 2.9-fold, and p36: 3.2-fold. (B) TCR-induced tyrosine protein phosphorylation in F528 p59~ ex- 
pressing cells. Cross-linking of BI-141 cell lines expressing the neomycin  marker (lanes 1-4), F528 p59~  T (lanes 5-8), F528 p59fY  ~  (lanes 9-/2) and, 
for comparison, F505 p56  ~  (lanes 13-16) was performed with anti-TCR mAb F23.1 +  RAM IgG for 2 rain at 37~  Lanes I and 2: Neo 1; 3 and 
4: Neo 2; 5 and 6: FynT F2; 7 and 8: FynT F7; 9 and 10: FynB F13; 11  and 12: FynB F15; 1.~ and 14: I.ck F7, and 15 and 16: l.ck Fg. Lanes 1, 
3, 5,  7, 9,  11,  13, and 15: RAM IgG alone and lanes 2, 4, 6,  8,  10,  12,  14, and 16: mAb F23.1 +  RAM IgG. Exposure: 10 h. Note that similar 
results were consistently obtained with several other randomly selected F528 p59~ expressing clones (data not shown). (C) Effects of coaggregation 
of TCR with CD45 on tyrosine protein phosphorylation. Cross-linking of BI-141 cell lines expressing the neomycin  marker (Neo 1; lanes 1-4), F528 
p59~ (FynT F2; lanes 5-8),  F528 p59b~ (FynB F13; lanes 9-12) and, for comparison, F505 p56  let (l.ck Fg; lanes 13-16) was performed using bi- 
otinylated primary antibodies and avidin for 5 min at 37~  as described. Lanes I, 5, 9, and 13: avidin alone; lanes 2, 6, 10, and 14:anti-CD45  mAb 
30-Fll  +  avidin; lanes 3, 7, 11, and 15: anti-TCR mAb F23.1 +  avidin, and lanes 4, 8, 12, and 16: mAb F23.1 +  mAb 30-Fll  +  avidin. Exposure: 
12 h.  (Right) Positions of molecular weight markers. (Left) Major tyrosine phosphorylation substrates. 
trol Neo cells  (Fig.  4  B).  These levels were comparable to 
the amounts  detected in F528 p59~ expressing cells.  Fur- 
ther analysis by antiphosphotyrosine immunoblot (Fig. 4 C) 
showed that cells expressing the inactive versions offynT (Fig. 
4  C,  lanes 5-8)  or fynB  (Fig.  4  C,  lanes  9-I2)  had TCR- 
induced tyrosine phosphorylation signals that were comparable 
to those of Neo cells (Fig. 4  C,  I-4). Moreover, these cells 
failed to demonstrate enhanced II-2 responses to stimulation 
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Figure 3.  Ib2  assays. (A) II.,2 
production in response to various 
concentrations of anti-TCR mAb 
F23.1  was assayed as indicated in 
Materials and Methods, using F528 
F59~  T and F528 p59~ expressing 
BI-141 cells, and compared with that 
of BI-141 dories expressing the ne- 
omycin  marker  alone.  Ordinate: 
[3H]thymidine  incorporation  in 
cpm; abscissa: antibody concentra- 
tion. Zero point on abscissa shows 
spontaneous IL-2 release.  (/3) and 
(C). Ib2 production in response to 
various  concentrations of beef in- 
sulin  in  association  with  AaA  ab k 
class II MHC was tested, using F528 
p59~T and F528 p59~ expressing 
BI-141 cells, and compared with that 
of BI-141 clones ~pressing the ne- 
omycin marker alone (13 and C), 
F505  p56  ~' or mouse CD4  (C). 
Two representative independent ex- 
periments are shown in B and C, 
respectively. Ordinate: pH]thymi- 
dine incorporation in cpm; abscissa: 
beef  insulin  concentration.  Zero 
point on abscissa  shows spontaneous 
Ib2 release.  Consistently  reproduc- 
ible  results were ob~ned with other 
randomly selected F528 p59~ ex- 
pressing cell lines (data not shown). 
with antigen (Fig. 4/9) or anti-TCR antibodies  (data not 
shown). Similarly, the BI-141 derivatives overexpressing wild- 
typefynT orfynB proteins (Fig. 5 A) did not show improved 
responsiveness to antigen (Fig. 5, B). Therefore, lack of the 
regulatory COOH-terminal site of tyrosine phosphorylation 
(tyrosine 528) is critical for enhancement of antigen respon- 
siveness by fynT. 
Discussion 
The  results presented  in this  report  show  that  activated 
p59~  T and p59  f~ efficiently enhance anti-TCR antibody- 
induced responses in the murine T cell hybridoma BI-141. 
This finding is consistent with the results of others (9) and 
further implicates p59f~ in the regulation of T cell receptor 
signaling.  It is interesting,  however, that even though the 
two proteins were expressed at equivalent levels, only acti- 
vated p59~  T efficiently increased T cell responsiveness to an- 
tigen stimulation. This observation  strongly suggests that 
fynT serves as a tissue-specific function in T  lymphocytes. 
It was intriguing to note that despite the distinct effects 
of p59~  T and p59~ on antigen-induced T cell responses, 
we failed to detect consistent qualitative or quantitative differ- 
ences in the ability of these two polypeptides to improve T 
cell responses to antibody stimulation, induding tyrosine pro- 
tein phosphorylation and lymphokine production. Consis- 
tently, we found that bothfyn isoforms had apparently similar 
in vitro tyrosine protein kinase activities and seemed capable 
of physically  interacting with the TCK compl~ (D. Davidson 
and A.  Veillette,  unpublished observations).  Although it 
1488  Regulation of T  Cell Function by p59~ Figure 4.  Effects  of kinase-negative p59~ polypeptides on T cell responsiveness. (A) Northern blot analysis. Expression of retroviralfyn transcripts 
was assayed in donal BI-141 cell lines expressing the neomycin phosphotransferase alone (lane I), M296F528 p59~  T (lanes 2-5), M296F528 p59fy  ~u 
(lanes 6 and 7), and, for comparison, F528 p59~ (lanes 8 and 9). Lanes I: Neo 2; 2: FynT MF4; 3: FynT MF6; 4: FynT MFS; 5: FynT MF11; 6: 
FynB MF8; 7: Fyn B MFll; 8: FynT F12, and 9: FVnB F13. In this experiment, a full-length MM23fynT cDNA was used as a probe. (I,,.) Retroviml 
fyn transcript position. (Right)  28,5 and 18S ribosomal KNA positions. The two RNA species migrating at 3.7 and 2.8 kb are the endogenous  fyn 
transcripts (3-6).  Exposure: 6 h. (B)fyn immunoblot. As in Fig. 1 C. Lanes I  and 2: Neo; 3: FynT MF4; 4: FynT  MF6; 5: ~  MF8; 6: FynT 
MFll;  7: FynB MF8; 8: FynB MFll; 9: FynT F2, and 10: FynB F13. (Left) Position of p59~, and (right) positions of molecular weight markers. 
Exposure: 8 h. The rehtive amounts offyn in M296F528 p59~ expressing cell lines (compared  with the average of Neo cells) are: FynT MF4: 2.1-fold; 
FvnT MF6: 2.0-fuld; FynT  MFS: 2.3-fold; PynT  MF11: 1.7-fold; F-TnB MF8: 2.1-fold, and Fyn.B  MFll: 2.1-fold. (C) Effects of TCK aggregation on 
tyrosine protein phosphorylation. As in Fig. 2 B. Crosslinking was performed with mAb F23.1 and RAM IgG for 2 min at 37~  Lanes 1 and 2: 
Neo 1; 3 and 4: Neo 2; 5 and 6: FynT  MF4; 7 and 8: FynT MF8; 9 and 10: FynB MF8; 11 and 12: FynB MFll; 13 and 14: FynT F2, and 15 and 
I6: FynB F13. Lanes I, 3, 5, 7, 9, 1I, 13, and 15: RAM IgG alone and lanes 2, 4, 6, 8, 10, 12, 14, and 16: mAb F23.1 +  RAM IgG. (Right) Positions 
of molecular weight markers, and (left) major tyrosine phosphorylation substrates. The immunoreactive spedes detected in all hnes at 54-56 kD is 
the H chain of IgG. Exposure: 10 h. (D) Antigen stimulation assay. Different donal BI-141 cell lines expressing M296F528 p59~ were tested for 
beef insulin reactivity and compared with other BI-141 derivatives, as described in Fig. 3 B. 
1489  Davidson  et al. Figure 5.  Effects  of wild-type p59b~ polypeptides  on T  cell responsiveness. (A)fyn  immunoblot. As in Fig.  1 C. Lanes I: BI-141; 2: Neo 2; 3: 
Neo 4; 4: FynT wt6; 5: FynT wt7; 6: FynT wt12;  7: FynB wt2; 8: FynT F2, and 9: FynB F13. (Left) Position of p59~, and (right) positions of molec- 
ular weight markers. Exposure:  10 h. The relative amounts off),n in wild-type  p59b~ expressing cell lines (compared with the average of Neo cells) 
are: FynT wt6: 2.5-fold; FynT wt7: 3.1-fold; FynT wt12: 2.4-fold,  and FynB wt 2: 2.1-fold. (B) Antigen stimulation  assay. Different  clonal BI-141 
cell lines overexpressing wild-type p59~ proteins were tested for beef insulin reactivity  and compared with other BI-141 derivatives, as described in 
Fig. 3B. 
should be noted that distinctions  in substrate specificity or 
catalytic function may have been masked by the stimulation 
provided by anti-TCR antibodies, an alternative explanation 
for our results is that the enhancement of TCR-induced tyro- 
sine protein phosphorylation by activatedfyn is insuf~cient 
to ameliorate  response to antigen/MHC stimulation. Through 
its unique sequences, p59~  T may regulate additional cellular 
pathways which further modulate T  cell responsiveness to 
antigen/MHC. These yet unidentified targets could be other 
signal-transducing  molecules, adhesion molecules, or cyto- 
skeletal constituents.  Although the ranges of overexpression 
typically allowed by retrovirus-mediated gene transfer did not 
permit further overexpression of thefyn isoforms in BI-141 
cells, it would be of interest  to test whether a marked in- 
crease in expression  of activated fynB in a permissive ex- 
perimental system could mimic the ability offynT to enhance 
physiological antigen receptor-mediated  responses. 
Based on the findings reported herein, we postulate  that 
fynT must participate in regulatory pathways involved in cou- 
pling TCR  stimulation by antigen/MHC to lymphokine 
production. It is interesting that a related function was re- 
cently ascribed to the ~" chain of the TCR complex (30). De- 
letion of the cytoplasmic tail of ~" significantly decreased the 
ability of this molecule to link antigen/MHC-induced TCR 
stimulation to lymphokine production.  As is the case for 
p59~  a3, this defect could be bypassed by stimulation with 
high a~nity anti-TCR mAbs. These provocative similarities 
suggest  that the function provided by the cytoplasmic tail 
of ~" is mediated either directly or indirectly through p59~  r. 
Further support for this view is lent by the observation that 
a fraction of p59b~T can be found associated with TCR in 
mild detergent lysates of T  lymphocytes  (8). 
Our data, as well as other published results (9, 16), show 
that activated versions of the two src-related tyrosine protein 
kinases abundantly expressed in T cells (p59  I~T and p56  kk) 
can enhance antigen receptor-mediated  functions.  It is im- 
portant that this is in contrast with p60  're, a member of the 
src family not normally expressed in T lymphocytes. Expres- 
sion of an activated version of this tyrosine  protein kinase 
in antigen-specific T cells fails to improve antigen receptor- 
induced signals, despite its ability to spontaneously enhance 
T  cell  tyrosine  protein  phosphorylation  and lymphokine 
production (31, and our unpublished data). 
Whereas the regulatory interactions  between p561ok and 
CD4/CD8 are well established (2), the physiological  processes 
allowing the activation of p59~ in T cells are unfortunately 
poorly understood. As fynT can associate with TCR, it has 
been proposed  that  the  enzymatic function of p59~  T is 
directly regulated by TCR. However, the in vitro catalytic 
activity of p59~  T is not enhanced upon antibody stimula- 
tion of TCR (8, and our unpublished observations). While 
this finding does not preclude the view that p59~T may be 
regulated through physical interactions  with TCR, it may 
indicate that the function of this enzyme is controlled through 
1490  Regulation  of T  Cell  Function by p59~ a more complex machinery.  For example, fynT may first be 
activated by CD45-mediated dephosphorylation of tyrosine 
528 (1). Subsequently, as suggested by our observations, TCR 
stimulation may allow activated p59~ T molecules to effec- 
tively interact  with  and/or  phosphorylate  their  substrates. 
These events may be prohibited by coaggregation of TCR 
with CD45, possibly as a result of a decrease in the activity 
of p59~ T by CD45 approximation,  or as a consequence of 
substrate dephosphorylation. A related model has been pro- 
posed for the regulation of the function of activated p56  L:k 
molecules in T  calls (16).  Despite the fact that  the basis of 
these phenomena remains largely undefined, it is becoming 
increasingly clear that through both distinct, as well as over- 
lapping, regulatory processes,  p59~  T and p56  l~ play impor- 
tant  roles in  the sigual transduction  of T  cell activation. 
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